Skip to main content
Signal8

Santhera Pharmaceuticals Holding AG (SPHDF)

Sector: Biotechnology

Industry: Biotechnology

Santhera Pharmaceuticals Holding AG logo

Santhera Pharmaceuticals Holding AG

OTC:SPHDFHealthcare
CLOSED
Mkt Cap$280.12M
EV-
Float10.98M
O/S15.31M
VOL110 sh
$ Vol$2K
Inst Own-
SI1.5%
Net Cash/Sh-
EarningsApr 29 · in 5mo
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 16, 202622.8522.8518.3018.30100
Nov 13, 202618.3018.3018.3018.30100
Nov 12, 202618.3018.3018.3018.30100
Nov 11, 202618.3018.3018.3018.30100
Nov 10, 202618.3018.3018.3018.30100
Nov 9, 202618.3018.3018.3018.30100
Nov 6, 202618.3018.3018.3018.30100
Nov 5, 202618.3018.3018.3018.30100
Nov 4, 202618.3018.3018.3018.30100
Nov 3, 202618.3018.3018.3018.30100
Oct 30, 202618.3018.3018.3018.30100
Oct 29, 202618.3018.3018.3018.30100
Oct 28, 202618.3018.3018.3018.30100
Oct 27, 202618.3018.3018.3018.30100
Oct 26, 202618.3018.3018.3018.30100
Oct 23, 202618.3018.3018.3018.30100
Oct 21, 202618.3018.3018.3018.30100
Oct 20, 202618.3018.3018.3018.30100
Oct 19, 202618.3018.3018.3018.30100
Oct 16, 202618.3018.3018.3018.30100
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.

The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy.

Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.

Key Metrics
Market Cap$280.12M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 15.31M shares outstanding

SectorHealthcare
IndustryMedical - Pharmaceuticals
ExchangeOTC
CountryCHCH
IPO DateApr 17, 2014
Shares Outstanding15.31M
Authorized Shares
Float10.98M
52-Week Range
Volume
Average Daily Volume--

30d Avg

--

60d Avg

110

90d Avg

355

Earnings
Dividend History
No dividend history available